Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Canadian privacy regulators are urging governments to require privacy protections, oversight and accountability for AI systems used in health care and health research.
The 53 member states of the WHO European Region adopted a shared roadmap for integrating artificial intelligence into health systems through 2033.
SpendRule raised $4 million in seed funding for its AI platform, which checks vendor invoices against contract terms and flags potential overpayments.
A Pew Research Center survey finds Americans are open to AI handling some healthcare tasks, but most want human review and remain uncomfortable with its use in diagnosis and treatment.
ALLOX raised $10.5 million in seed funding to expand its drug discovery platform and advance its small molecule research programs.
Flagship Pioneering formed Etcelera by combining Cellarity, Etiome and Empress Therapeutics into an AI drug discovery company.
The HTI-5 final rule removes 14 health IT certification criteria, including a requirement for AI model cards, and revises seven others.
Eli Lilly will use the SpeechDx dataset to study speech as a marker for Alzheimer's disease risk and cognitive decline.
Formation Bio formed a $600 million fund to acquire and advance 10 to 15 clinical stage drug programs over the next three to five years.
Zocdoc is opening its healthcare booking infrastructure to registered AI agents and partnering with Instinct to support provider searches, insurance checks and confirmed appointments.
Insilico Medicine reported a 40% objective response rate at the 130 mg dose of ISM6331 in a small group of participants with mesothelioma.
UnitedHealthcare is expanding access to its Avery generative AI assistant from about 6.7 million members to 21 million. The insurer says Avery resolves 90% of member interactions without human support.
Swiss biotech startup Atlas Bio raised $12.5 million to develop an AI model that simulates drug efficacy and safety in virtual patients.
University of Leeds spinout adsilico raised £10 million to expand its virtual patient technology for testing medical devices before clinical trials.
Vera Health raised a $28.5 million Series A to expand its clinical evidence search platform, which is used by more than 800,000 clinicians across 190 countries.
Baba, an AI care company for Medicare and Medicaid patients, raised a $40 million Series A led by FirstMark.
Google Research is expanding tuberculosis screening tools based on chest X rays, cough audio and open models. Its technology supports clinical deployments in Africa and a national screening program in Indonesia.
Lunit and Summit Therapeutics will use the Lunit SCOPE IO pathology platform to analyze tumor tissue images for research involving ivonescimab.
Pathos AI raised $237 million in a Series E round led by Bristol Myers Squibb. The company will expand its Foundry AI platform and advance four oncology drug candidates.
BioVid has launched Mimetics, a research platform that models how physicians assess evidence and make treatment decisions. The company says validation tests found an 80% to 90% match between synthetic and human physician groups.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
